Search results for abx831411

Tomaralimab, Abbexa, abx831411

Tomaralimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting TLR2/CD282, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).